These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19098687

  • 1. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G, Roy S.
    Menopause; 2009; 16(2):272-8. PubMed ID: 19098687
    [Abstract] [Full Text] [Related]

  • 2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 3. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD, Stanczyk FZ, Mullin P, Saadat P, Jafarian N, Sokol RZ.
    Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
    [Abstract] [Full Text] [Related]

  • 5. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.
    Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):649-54. PubMed ID: 8547832
    [Abstract] [Full Text] [Related]

  • 6. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
    Jiroutek MR, Chen MH, Johnston CC, Longcope C.
    Menopause; 1998 Sep; 5(2):90-4. PubMed ID: 9689202
    [Abstract] [Full Text] [Related]

  • 7. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 8. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 9. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison MC, Haller I, Rabkin J.
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT, Tangpricha V, Weinberg J, Malabanan AO, Chimeh FN, Holick MF.
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [Abstract] [Full Text] [Related]

  • 11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 12. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women.
    Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL.
    Nutr Cancer; 2001 Jan; 39(1):58-65. PubMed ID: 11588903
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
    White T, Jain JK, Stanczyk FZ.
    Am J Obstet Gynecol; 2005 Jun; 192(6):2055-9. PubMed ID: 15970897
    [Abstract] [Full Text] [Related]

  • 14. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 20; 14(7):1660-5. PubMed ID: 16030098
    [Abstract] [Full Text] [Related]

  • 16. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J.
    Fertil Steril; 2007 Aug 20; 88(2):383-9. PubMed ID: 17561009
    [Abstract] [Full Text] [Related]

  • 17. Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women.
    Hirshman E, Merritt P, Wang CC, Wierman M, Budescu DV, Kohrt W, Templin JL, Bhasin S.
    Horm Behav; 2004 Feb 20; 45(2):144-55. PubMed ID: 15019802
    [Abstract] [Full Text] [Related]

  • 18. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2008 May 20; 110(1-2):1-9. PubMed ID: 18359622
    [Abstract] [Full Text] [Related]

  • 19. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement.
    Kos-Kudla B, Ostrowska Z, Marek B, Ciesielska-Kopacz N, Kudla M, Kajdaniuk D, Siemidska L, Strzelczyk J.
    Endocr Regul; 2001 Dec 20; 35(4):217-22. PubMed ID: 11858769
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
    Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2007 Oct 20; 107(1-2):57-69. PubMed ID: 17627814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.